CH544119A - Verfahren zur Herstellung von optisch aktiven Thiadiazolen - Google Patents

Verfahren zur Herstellung von optisch aktiven Thiadiazolen

Info

Publication number
CH544119A
CH544119A CH369972A CH369972A CH544119A CH 544119 A CH544119 A CH 544119A CH 369972 A CH369972 A CH 369972A CH 369972 A CH369972 A CH 369972A CH 544119 A CH544119 A CH 544119A
Authority
CH
Switzerland
Prior art keywords
thiadiazoles
preparation
optically active
optically
active
Prior art date
Application number
CH369972A
Other languages
English (en)
Inventor
Maurice Weinstock Leonard
James Tull Roger
Michael Mulvey Dennis
Original Assignee
Frosst & Co Charles E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frosst & Co Charles E filed Critical Frosst & Co Charles E
Priority claimed from US00370994A external-priority patent/US3812182A/en
Priority claimed from US05/417,301 external-priority patent/US3962338A/en
Priority claimed from US425912A external-priority patent/US3892744A/en
Publication of CH544119A publication Critical patent/CH544119A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH369972A 1968-05-22 1969-05-21 Verfahren zur Herstellung von optisch aktiven Thiadiazolen CH544119A (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US73133368A 1968-05-22 1968-05-22
US81847469A 1969-04-21 1969-04-21
US81808669A 1969-04-21 1969-04-21
US81809069A 1969-04-21 1969-04-21
US17223071A 1971-08-16 1971-08-16
US17223271A 1971-08-16 1971-08-16
US17223171A 1971-08-16 1971-08-16
US17914771A 1971-09-09 1971-09-09
US17914571A 1971-09-09 1971-09-09
US28401372A 1972-08-25 1972-08-25
US00370994A US3812182A (en) 1968-05-22 1973-06-18 S-bis-(2-lower alkyl amino hydroxy-methylethoxy)-methanes
US05/417,301 US3962338A (en) 1968-05-22 1973-11-19 Novel methods and compounds employed therein
US425912A US3892744A (en) 1968-05-22 1973-12-18 Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles

Publications (1)

Publication Number Publication Date
CH544119A true CH544119A (de) 1973-12-28

Family

ID=27584550

Family Applications (5)

Application Number Title Priority Date Filing Date
CH369972A CH544119A (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von optisch aktiven Thiadiazolen
CH369872A CH553214A (de) 1968-05-22 1969-05-21 Verfahren zur herstellung von optisch aktiven thiadiazolen.
CH584972A CH543478A (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von Glykolaminen
CH776169A CH560710A5 (de) 1968-05-22 1969-05-21
CH369772A CH554887A (de) 1968-05-22 1969-05-21 Verfahren zur herstellung von optisch aktiven thiadiazolen.

Family Applications After (4)

Application Number Title Priority Date Filing Date
CH369872A CH553214A (de) 1968-05-22 1969-05-21 Verfahren zur herstellung von optisch aktiven thiadiazolen.
CH584972A CH543478A (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von Glykolaminen
CH776169A CH560710A5 (de) 1968-05-22 1969-05-21
CH369772A CH554887A (de) 1968-05-22 1969-05-21 Verfahren zur herstellung von optisch aktiven thiadiazolen.

Country Status (10)

Country Link
US (3) US3657237A (de)
AT (3) AT305229B (de)
BE (1) BE733387A (de)
CA (1) CA949069A (de)
CH (5) CH544119A (de)
DE (1) DE1925955A1 (de)
FR (2) FR2039306B1 (de)
GB (2) GB1267328A (de)
NL (1) NL153189B (de)
SE (2) SE388613B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892744A (en) * 1968-05-22 1975-07-01 Merck & Co Inc Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles
JPS4913176A (de) * 1972-06-03 1974-02-05
US3891639A (en) * 1973-04-19 1975-06-24 Merck Sharp & Dohme 4-{8 3-Amino-2-acyloxypropoxy{9 -1,2,5-thiadiazole compounds
US4011217A (en) * 1973-04-19 1977-03-08 Merck Sharp & Dohme (I.A.) Corporation 4-(3-amino-2-acyloxypropoxy)-1,2,5-thiadiazole compounds
AU509371B2 (en) * 1975-08-07 1980-05-08 F. Hoffmann-La Roche Ag Diazepine Derivatives
US4097490A (en) * 1975-09-25 1978-06-27 Merck & Co., Inc. Pyroglutamic acid salts of t-butylamino-2,3-dihydroxypropane
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
ZA805250B (en) * 1979-09-04 1981-09-30 Bristol Myers Co Chemical compounds
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4550117A (en) * 1982-07-26 1985-10-29 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines, derivatives thereof, having anti-hypertensive activity
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
US5320839A (en) * 1991-10-11 1994-06-14 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
US5523301A (en) * 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
US5929247A (en) * 1994-10-24 1999-07-27 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
TWI293087B (en) * 2003-02-05 2008-02-01 Hitachi Chemical Co Ltd Friction material composition and friction material using thereof
US7090548B1 (en) * 2005-02-03 2006-08-15 International Business Machines Corporation Method of using a linear propulsor array for propulsion and navigation
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2050441A1 (de) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Verwendung von Beta-Blockern für die Herstellung eines Medikaments zur Behandlung von Hämangiomen
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2964530A (en) * 1958-05-02 1960-12-13 Sterling Drug Inc 3-alkyl-4-hydroxymethyl-4-alkyloxazolidines

Also Published As

Publication number Publication date
DE1925955A1 (de) 1970-10-29
GB1264558A (de) 1972-02-23
NL6907872A (de) 1969-11-25
AT305229B (de) 1973-02-12
US3781284A (en) 1973-12-25
CH543478A (de) 1973-12-14
BE733387A (de) 1969-11-21
FR2039306B1 (de) 1974-03-22
US3657237A (en) 1972-04-18
SE7410837L (de) 1974-08-27
SE388613B (sv) 1976-10-11
US3766180A (en) 1973-10-16
CH553214A (de) 1974-08-30
FR2039306A1 (de) 1971-01-15
FR2116583A1 (de) 1972-07-13
CH554887A (de) 1974-10-15
NL153189B (nl) 1977-05-16
GB1267328A (en) 1972-03-15
CH560710A5 (de) 1975-04-15
SE421001B (sv) 1981-11-16
AT294830B (de) 1971-12-10
AT289788B (de) 1971-05-10
FR2116583B1 (de) 1982-03-19
CA949069A (en) 1974-06-11

Similar Documents

Publication Publication Date Title
CH544119A (de) Verfahren zur Herstellung von optisch aktiven Thiadiazolen
CH507249A (de) Verfahren zur Herstellung von 2-Brom-a-ergokryptin
AT306930B (de) Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen
AT291254B (de) Verfahren zur herstellung von 3-amino-4jod-5-methyllisoxazolen
AT296964B (de) Verfahren zur Herstellung von 1-Hydroxyphenyl-2-aminoäthanolen
AT289084B (de) Verfahren zur Herstellung von Trimethyl-p-benzochinon
AT295757B (de) Verfahren zur Herstellung von Benzindenen
AT294064B (de) Verfahren zur Herstellung von 1-Alkyl-2-aminomethylpyrrolidinen
AT296254B (de) Verfahren zur Herstellung von 2-Acyloxythionobenzamiden
CH486444A (de) Verfahren zur Herstellung von 7-Cyan-cumarinen
CH511851A (de) Verfahren zur Herstellung von 2-Oxychinolinen
AT314097B (de) Verfahren zur Herstellung von 19-Norsteroiden
AT292205B (de) Verfahren zur Herstellung von 1-Peracylglykosyl-5-azacytosinen
AT286252B (de) Verfahren zur Herstellung von 3-Aminopropanolen
CH502332A (de) Verfahren zur Herstellung von optisch aktivem (-)-Zearalenon-4-mono-äther-2-(-)-menthoxyacetat
AT289737B (de) Verfahren zur Herstellung von Sulfatobetainen
CH505089A (de) Verfahren zur Herstellung von 3-substituierten-7-Aminocumarinen
AT296251B (de) Verfahren zur Herstellung von Methylcyclohexenen
CH513141A (de) Verfahren zur Herstellung von Glyoxaldithiosemicarbazonen
AT290555B (de) Verfahren zur Herstellung von Triorganosilanolen
AT291577B (de) Verfahren zur Herstellung von Polyacyloxamidrazonen
CH484975A (de) Verfahren zur Herstellung von Polyacyloxamidrazonen
CH487927A (de) Verfahren zur Herstellung von 7-Triazolyl-cumarinen
CH514524A (de) Verfahren zur Herstellung von Cyclopent-2-enyl-phenolen
CH489527A (de) Verfahren zur Herstellung von 7-Triazinyl-cumarinen

Legal Events

Date Code Title Description
PL Patent ceased